Pyrimidine Thioethers: A Novel Class of HIV-1 Reverse Transcriptase Inhibitors with Activity Against BHAP-Resistant HIV
Journal of Medicinal Chemistry1998Vol. 41(20), pp. 3793–3803
Citations Over TimeTop 16% of 1998 papers
Richard A. Nugent, Stephen T. Schlachter, Michael J. Murphy, Gary J. Cleek, Toni J. Poel, Donn G. Wishka, David R. Graber, Yoshihiko Yagi, Barbara J. Keiser, Robert A. Olmsted, Laurie A. Kopta, Steven Swaney, Susan M. Poppe, Joel Morris, W. Gary Tarpley, Richard C. Thomas
Abstract
A series of pyrimidine thioethers was synthesized and evaluated for inhibitory properties against wild-type HIV-1 reverse transcriptase (RT) and an RT carrying the resistance-conferring mutation P236L. Modifications of both the pyrimidine and the functionality attached through the thioether yielded several analogues, which demonstrated activity against both enzyme types, with IC50 values as low as 190 nM against wild-type and 66 nM against P236L RT. Evaluation of a select number of pyrimidine thioethers in cell culture showed that these compounds have excellent activity against HIV-1IIIB-WT and retain good activity against a laboratory-derived HIV-1MF delavirdine-resistant variant.
Related Papers
- → Design of Annulated Pyrazoles as Inhibitors of HIV-1 Reverse Transcriptase(2008)74 cited
- → Quinoxapeptins: Novel Chromodepsipeptide Inhibitors of HIV-1 and HIV-2 Reverse Transcriptase. I. The Producing Organism and Biological Activity.(1996)52 cited
- → Mechanism of Inhibition of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase by d4TTP: an Equivalent Incorporation Efficiency Relative to the Natural Substrate dTTP(2000)37 cited
- → Design, synthesis and biological evaluation of substituted (+)-SG-1 derivatives as novel anti-HIV agents(2018)13 cited
- → Novel Modifications in the Alkenyldiarylmethane (ADAM) Series of Non-Nucleoside Reverse Transcriptase Inhibitors(1999)43 cited